FITC Anti-Human CD7 Antibody[124-1D1]

The FITC Anti-Human CD7 Antibody [124-1D1] is a highly specific and sensitive monoclonal antibody that has been designed for use in a variety of research applications. This antibody is specifically designed to target the CD7 antigen, which is a transmembrane glycoprotein that is expressed on the surface of T cells, NK cells, and some thymocytes.

The FITC Anti-Human CD7 Antibody [124-1D1] has been extensively tested and validated for use in flow cytometry, immunohistochemistry, and immunofluorescence assays. It has been shown to be highly specific and sensitive, with minimal cross-reactivity with other antigens.

This antibody is supplied in a convenient, ready-to-use format, and is available in a range of sizes to suit your specific needs. It has been purified using a combination of protein A and protein G chromatography, and is supplied in a phosphate-buffered saline solution containing 0.09% sodium azide as a preservative.

The FITC Anti-Human CD7 Antibody [124-1D1] is an essential tool for researchers studying the role of CD7 in T cell and NK cell biology, as well as in the diagnosis and treatment of various diseases. Its high specificity and sensitivity make it an ideal choice for use in a wide range of applications, including basic research, drug discovery, and clinical diagnostics.

Overall, the FITC Anti-Human CD7 Antibody [124-1D1] is a reliable and effective tool for researchers looking to study the CD7 antigen in human cells. Its high specificity, sensitivity, and convenience make it an essential component of any research program focused on T cell and NK cell biology.